These alterations result from an abnormal signal transduction, secondary to mutations in genes encoding tyrosine kinase proteins or related molecules (BCR-ABL1 fusion gene in CML and JAK2 V617F mutation in polycythemia vera) [7]. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.